Rhinology — MCQs

Rhinology Indian Medical PG Practice Questions and MCQs

Question 141: The nasal valve is formed by all except:

A. Septum
B. Middle turbinate (Correct Answer)
C. Lower end of upper lateral cartilage
D. Inferior turbinate

Explanation: **Explanation:** The **Internal Nasal Valve** is the narrowest part of the nasal airway and the primary site of resistance to airflow (the "bottleneck" of the nose). It is a three-dimensional space bounded by specific anatomical structures. **Why Middle Turbinate is the correct answer:** The middle turbinate is located posterior and superior to the internal nasal valve area. It does not contribute to the boundaries of this specific functional valve. Its primary roles are related to the drainage of the paranasal sinuses (middle meatus) and humidification, rather than the initial regulation of inspiratory airflow resistance. **Analysis of other options (Boundaries of the Nasal Valve):** * **Septum (Medial boundary):** The cartilaginous septum forms the rigid medial wall. * **Lower end of Upper Lateral Cartilage (Superior/Lateral boundary):** This is the most critical component. The angle between the septum and the ULC is normally **10–15 degrees**. * **Inferior Turbinate (Inferior/Lateral boundary):** The anterior head of the inferior turbinate forms the floor and lateral limit. Hypertrophy here is a common cause of nasal obstruction. * *Note: The floor of the nose (pyriform aperture) also contributes to the boundary.* **Clinical Pearls for NEET-PG:** * **Cottle’s Test:** Used to evaluate nasal valve stenosis. Lateral distraction of the cheek improves breathing if the valve is the site of obstruction. * **Poiseuille’s Law:** Since the nasal valve is the narrowest point, even minor structural deviations (like a septal spur) here result in significant increases in airway resistance. * **Surgical relevance:** Procedures like "spreader grafts" are used to widen the angle between the septum and the upper lateral cartilage to treat valve collapse.

Question 142: What is the treatment of choice in recurrent epistaxis in a patient with hereditary hemorrhagic telangiectasia?

A. Anterior ethmoidal artery ligation
B. Septal dermatoplasty (Correct Answer)
C. External carotid artery ligation
D. Internal carotid artery ligation

Explanation: **Explanation:** **Hereditary Hemorrhagic Telangiectasia (HHT)**, also known as **Osler-Weber-Rendu Syndrome**, is an autosomal dominant disorder characterized by fibrovascular dysplasia. This leads to the formation of fragile telangiectasias and arteriovenous malformations (AVMs) on mucosal surfaces. In the nose, these thin-walled vessels lack a contractile muscular layer, leading to profuse, recurrent epistaxis from minor trauma or even airflow. **Why Septal Dermatoplasty is the Correct Choice:** Septal dermatoplasty (**Saunders' Operation**) is the surgical treatment of choice for refractory or recurrent epistaxis in HHT. The procedure involves removing the diseased Schneiderian mucosa of the nasal septum and anterior turbinates and replacing it with a **split-thickness skin graft** (usually taken from the thigh). Skin is more resistant to trauma and does not contain the dysplastic vessels characteristic of HHT, thereby significantly reducing the frequency and severity of bleeding episodes. **Analysis of Incorrect Options:** * **A, C, and D (Arterial Ligations):** While ligation of the anterior ethmoidal or external carotid arteries may be used in acute, life-threatening epistaxis, they are **not definitive treatments** for HHT. In HHT, the pathology is widespread across the mucosa; ligating a proximal vessel often fails because collateral circulation develops rapidly, leading to recurrence. Internal carotid artery ligation is never indicated for epistaxis and carries a high risk of stroke. **Clinical Pearls for NEET-PG:** * **Triad of HHT:** Positive family history, recurrent epistaxis, and multiple telangiectasias (lips, tongue, fingers). * **First-line management:** Lubrication and moisturizing ointments to prevent crusting. * **Young’s Procedure:** In extreme cases of HHT, total closure of the nostrils (Young’s procedure) can be done to eliminate airflow and prevent mucosal drying/bleeding. * **Pharmacotherapy:** Bevacizumab (anti-VEGF) is an emerging systemic treatment for HHT.

Question 143: Apple jelly nodules on the nasal septum are found in which condition?

A. Tuberculosis
B. Lupus Vulgaris (Correct Answer)
C. Syphilis
D. Rhinoscleroma

Explanation: **Explanation:** **Lupus Vulgaris** is a chronic, progressive form of cutaneous tuberculosis caused by *Mycobacterium tuberculosis*. When it involves the nose, it typically affects the **nasal vestibule and the cartilaginous part of the nasal septum**. The characteristic clinical finding is the presence of **"Apple jelly nodules"**—small, reddish-brown, translucent tubercles. These are best visualized using **diascopy** (pressing a glass slide against the lesion), which causes the surrounding erythema to blanch, revealing the yellowish-brown "apple jelly" appearance of the underlying granuloma. **Analysis of Incorrect Options:** * **Tuberculosis (Systemic/Ulcerative):** While Lupus Vulgaris is a form of TB, "Apple jelly nodules" are specifically pathognomonic for the indolent, cutaneous/mucosal form (Lupus Vulgaris). Primary nasal TB usually presents as an ulcer or a friable mass. * **Syphilis:** Nasal syphilis typically presents with a "saddle nose" deformity (due to destruction of the bony septum) or gummas. It does not produce apple jelly nodules. * **Rhinoscleroma:** Caused by *Klebsiella rhinoscleromatis*, it is characterized by three stages: Catarrhal, Atrophic, and Nodular/Hypertrophic. Key histological findings include **Mikulicz cells** and **Russell bodies**, not apple jelly nodules. **High-Yield Clinical Pearls for NEET-PG:** * **Lupus Vulgaris:** Most common site is the nose/face; can lead to "beak-like" deformity due to destruction of the nasal alae. * **Diascopy:** The gold-standard clinical test to identify apple jelly nodules. * **Nasal Septum Perforation:** Lupus Vulgaris affects the **cartilaginous** septum, whereas Syphilis affects the **bony** septum.

Question 144: The Saccharin test is performed to assess which of the following?

A. Ciliary function (Correct Answer)
B. Blood sugar
C. Bronchial secretion
D. Kidney function

Explanation: The **Saccharin test** is a simple, non-invasive clinical bedside test used to evaluate **Mucociliary Clearance (MCC)**. ### Explanation of the Correct Answer **A. Ciliary function:** The nasal mucosa is lined with pseudostratified ciliated columnar epithelium. These cilia beat in a coordinated fashion to move mucus toward the nasopharynx. In this test, a small particle of saccharin (approx. 1 mm) is placed on the anterior end of the inferior turbinate. The patient is instructed not to sneeze or blow their nose. The time taken for the patient to perceive a sweet taste in the throat is measured. * **Normal Saccharin Transit Time:** 7 to 15 minutes. * **Abnormal:** >20 minutes suggests impaired ciliary function (e.g., Kartagener’s syndrome, Primary Ciliary Dyskinesia, or chronic sinusitis). ### Why Other Options are Incorrect * **B. Blood sugar:** While saccharin is a sugar substitute, this test measures transit time, not metabolic glucose levels. Blood sugar is assessed via Glucometer or laboratory venous samples. * **C. Bronchial secretion:** While cilia also exist in the bronchi, the Saccharin test specifically assesses the **nasal** mucociliary pathway. Bronchial secretions are typically evaluated via sputum analysis or bronchoalveolar lavage (BAL). * **D. Kidney function:** Kidney function is assessed via Serum Creatinine, Urea, and GFR, which have no physiological link to nasal ciliary transit. ### High-Yield Clinical Pearls for NEET-PG * **Primary Ciliary Dyskinesia (PCD):** A genetic defect in dynein arms. The triad of PCD, situs inversus, and bronchiectasis is known as **Kartagener’s Syndrome**. * **Gold Standard:** While the Saccharin test is a screening tool, the definitive diagnosis for ciliary motility disorders is **Electron Microscopy** of a ciliary biopsy or **High-speed Digital Video Microscopy**. * **Factors affecting MCC:** Smoking, atmospheric pollution, and viral infections (like Influenza) significantly prolong the saccharin transit time.

Question 145: The lamina papyracea separates the nasal cavity from which of the following structures?

A. Sphenoid bone
B. Orbit (Correct Answer)
C. Frontal bone
D. Maxillary sinus

Explanation: **Explanation:** The **lamina papyracea** (literally "paper-like layer") is a paper-thin, smooth, oblong bone that forms the lateral wall of the ethmoid labyrinth and the **medial wall of the orbit**. It serves as the primary anatomical barrier separating the ethmoidal air cells from the orbital contents. **Why the correct answer is right:** * **Option B (Orbit):** The lamina papyracea is the thin plate of the ethmoid bone that separates the ethmoid sinus (part of the nasal complex) from the orbit. Due to its extreme fragility, it is the most common site for the spread of infection from the paranasal sinuses into the orbit (leading to orbital cellulitis) and is frequently breached during Functional Endoscopic Sinus Surgery (FESS). **Why the incorrect options are wrong:** * **Option A (Sphenoid bone):** The sphenoid bone lies posterior to the ethmoid bone. The boundary here is the sphenoethmoidal recess, not the lamina papyracea. * **Option C (Frontal bone):** The frontal bone forms the roof of the orbit and the floor of the frontal sinus. It is superior to the ethmoid bone. * **Option D (Maxillary sinus):** The maxillary sinus is separated from the orbit by its roof (the orbital floor), and from the nasal cavity by the lateral nasal wall (inferior and middle meatus). **High-Yield Clinical Pearls for NEET-PG:** * **Orbital Cellulitis:** The most common cause of orbital cellulitis in children is ethmoid sinusitis spreading through the lamina papyracea. * **FESS Complication:** Accidental penetration of the lamina papyracea during surgery can lead to periorbital ecchymosis, orbital hematoma, or injury to the medial rectus muscle. * **Haller Cells:** These are infraorbital ethmoid cells that grow into the floor of the orbit/roof of the maxillary sinus, potentially narrowing the ostium.

Question 146: Ozaena is also known as which of the following conditions?

A. Hypertrophic rhinitis
B. Vasomotor rhinitis
C. Allergic rhinitis
D. Atrophic rhinitis (Correct Answer)

Explanation: **Explanation:** **Atrophic Rhinitis (Ozaena)** is a chronic inflammatory condition of the nasal mucosa characterized by progressive atrophy of the nasal mucosa and the underlying turbinate bones. The term "Ozaena" (derived from the Greek word for "stench") refers to the most characteristic feature of the disease: a foul-smelling discharge and the formation of thick, greenish-black crusts. **Why Option D is Correct:** In Atrophic Rhinitis, the ciliated columnar epithelium is replaced by stratified squamous epithelium. This leads to a loss of mucociliary clearance, resulting in the accumulation of stagnant secretions that dry up to form crusts. These crusts undergo putrefaction by saprophytic bacteria (like *Klebsiella ozaenae*), producing a characteristic fetid odor. Paradoxically, despite a wide nasal cavity (roomy nose), patients often complain of nasal obstruction due to sensory nerve atrophy. **Why Other Options are Incorrect:** * **A. Hypertrophic rhinitis:** Characterized by permanent thickening of the mucosa and turbinate hypertrophy (usually the inferior turbinate), often due to chronic irritation. * **B. Vasomotor rhinitis:** A non-allergic condition caused by autonomic instability, leading to episodic sneezing, rhinorrhea, and nasal congestion. * **C. Allergic rhinitis:** An IgE-mediated hypersensitivity reaction to allergens, presenting with paroxysmal sneezing, watery discharge, and itching. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Primary Atrophic Rhinitis (HERNIA):** **H**ereditary, **E**ndocrine (puberty/females), **R**acial, **N**utritional (Vitamin A, D, or Iron deficiency), **I**nfective, **A**utoimmune. * **Merciful Anosmia:** The patient is unaware of the foul smell because their own olfactory epithelium has atrophied. * **Surgical Management:** **Young’s operation** or Modified Young’s operation (aims to close the nostrils to allow the mucosa to heal). * **Woodman’s Solution:** Used for nasal irrigation to clear crusts.

Question 147: What is the most common site of leakage in CSF rhinorrhea?

A. Sphenoid sinus
B. Frontal sinus
C. Cribriform plate (Correct Answer)
D. Tegmen tympani

Explanation: **Explanation:** CSF rhinorrhea occurs when there is a breach in the bone, dura mater, and arachnoid membrane, allowing cerebrospinal fluid to escape into the nasal cavity. **Why the Cribriform Plate is Correct:** The **cribriform plate of the ethmoid bone** is the most common site for spontaneous and traumatic CSF leaks. This is due to its unique anatomy: it is the thinnest portion of the skull base (often only 0.05 mm thick) and is intimately perforated by the olfactory nerve filaments. These perforations create natural points of weakness where the dura is tightly adherent, making it highly susceptible to fractures during head trauma or erosions due to increased intracranial pressure. **Analysis of Incorrect Options:** * **Sphenoid Sinus:** While a common site for leaks following transsphenoidal surgery or in cases of "empty sella syndrome," it is less frequent than the ethmoid roof/cribriform area. * **Frontal Sinus:** Leaks here usually follow significant anterior skull base trauma. While clinically important, the thick posterior wall of the frontal sinus makes it less common than the cribriform plate. * **Tegmen Tympani:** This is the most common site for **CSF otorrhea** (leakage into the middle ear). If the tympanic membrane is intact, fluid may flow down the Eustachian tube and present as "paradoxical CSF rhinorrhea," but it is not the most common primary site for rhinorrhea. **Clinical Pearls for NEET-PG:** * **Most common cause:** Non-iatrogenic trauma (accidents). * **Diagnostic Gold Standard:** Beta-2 Transferrin assay (most specific biochemical marker). * **Imaging of choice:** High-Resolution CT (HRCT) of the paranasal sinuses to identify the bony defect. * **Target Sign/Halo Sign:** Seen when CSF is mixed with blood on a paper/linen (CSF forms a clear outer ring).

Question 148: What is the management of a rhinolith?

A. Medical management
B. Surgical management (Correct Answer)
C. No treatment required
D. Symptomatic treatment only

Explanation: **Explanation:** A **rhinolith** is a calcareous concretion formed by the gradual deposition of mineral salts (calcium and magnesium) around an endogenous or exogenous foreign body (nidus) in the nasal cavity. **Why Surgical Management is Correct:** The definitive treatment for a rhinolith is **surgical removal**. Because these masses are hard, irregular, and often impacted within the nasal passage, they cannot be dissolved by medication or expelled spontaneously. Most rhinoliths can be removed **endonasally** (through the nostrils) under local or general anesthesia. Large or neglected rhinoliths may require fragmentation before removal or, rarely, a lateral rhinotomy approach if they are excessively large. **Why Other Options are Incorrect:** * **Medical management:** There are no pharmacological agents that can dissolve the mineralized matrix of a rhinolith. Antibiotics may treat secondary infections but will not remove the underlying cause. * **No treatment required:** If left untreated, rhinoliths cause chronic foul-smelling unilateral nasal discharge, epistaxis, nasal obstruction, and can lead to complications like septal perforation or oronasal fistulas. * **Symptomatic treatment only:** Treating symptoms (like pain or congestion) without removing the physical obstruction leads to recurrence and worsening of the condition. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Presentation:** A patient (often an adult) presenting with **unilateral, foul-smelling, purulent nasal discharge** and nasal obstruction. * **Diagnosis:** Usually clinical (anterior rhinoscopy) but confirmed by **Non-Contrast CT (NCCT) Paranasal Sinuses**, which shows a radio-opaque mass with a "stippled" appearance. * **Composition:** Primarily Calcium phosphate, Calcium carbonate, and Magnesium phosphate. * **Differential Diagnosis:** Must be distinguished from antrochoanal polyps, nasal osteomas, or malignancies.

Question 149: The nasal cycle is the cyclical alternate nasal blockage that occurs:

A. Every 6-12 hours
B. Every 4-12 hours
C. Every 6-8 hours (Correct Answer)
D. Every 12-24 hours

Explanation: **Explanation:** The **nasal cycle** is a physiological phenomenon characterized by the rhythmic, alternating congestion and decongestion of the nasal venous plexuses (cavernous tissue) in the turbinates. This process is regulated by the autonomic nervous system. **1. Why Option C is Correct:** In the majority of healthy individuals (approx. 80%), the nasal cycle occurs every **6 to 8 hours** (though some textbooks cite a range of 2–8 hours, 6–8 is the most commonly tested standard in postgraduate exams). While one side of the nose undergoes vasoconstriction (opening the airway), the other undergoes vasodilation (causing partial blockage). This allows the respiratory epithelium on each side to periodically "rest" and recover its moisture, preventing the mucosa from drying out. **2. Why Other Options are Incorrect:** * **Options A & B (4–12 or 6–12 hours):** These ranges are too broad. While the cycle can vary based on age, posture, and humidity, the physiological mean remains shorter than 12 hours. * **Option D (12–24 hours):** This is far too long. A cycle lasting this long would likely indicate a pathological state or a permanent anatomical obstruction (like a deviated nasal septum) rather than a physiological cycle. **Clinical Pearls for NEET-PG:** * **Total Airway Resistance:** Despite the alternating blockage, the **total nasal resistance remains constant**, meaning the person is usually unaware of the cycle. * **Regulation:** It is controlled by the **hypothalamus**. Sympathetic activity causes decongestion, while parasympathetic activity causes congestion. * **Clinical Significance:** The nasal cycle is abolished by general anesthesia and can be exaggerated in patients with a deviated nasal septum (DNS), leading to "paradoxical nasal obstruction."

Question 150: What is the treatment of Rhinitis Medicamentosa?

A. Withdrawal of nasal drops with a short course of steroids (Correct Answer)
B. Antibiotics
C. Polypectomy
D. Increasing the dose of the nasal drops

Explanation: **Explanation:** **Rhinitis Medicamentosa (RM)** is a condition of rebound nasal congestion caused by the prolonged use (typically >5–7 days) of topical nasal decongestants (e.g., Oxymetazoline, Xylometazoline). These drugs are sympathomimetic amines that cause vasoconstriction; chronic use leads to down-regulation of alpha-receptors and compensatory vasodilation, resulting in a "rebound" effect. **Why Option A is Correct:** The primary goal of treatment is to break the cycle of dependency. 1. **Withdrawal:** Immediate cessation of the offending topical decongestant is mandatory to allow the nasal mucosa to recover. 2. **Steroids:** A short course of systemic steroids (e.g., Prednisolone) or potent topical nasal steroid sprays (e.g., Fluticasone) is used to reduce mucosal edema and inflammation, making the withdrawal period tolerable for the patient. **Why Other Options are Incorrect:** * **Option B (Antibiotics):** RM is a drug-induced physiological change, not a bacterial infection. Antibiotics have no role unless there is a secondary bacterial rhinosinusitis. * **Option C (Polypectomy):** RM involves hypertrophy of the turbinates, not nasal polyps. Surgical intervention (like turbinoplasty) is only considered if medical management fails. * **Option D (Increasing dose):** This would exacerbate the tachyphylaxis and worsen the mucosal damage (squamous metaplasia and loss of ciliary function). **High-Yield NEET-PG Pearls:** * **Clinical Presentation:** Patients often complain of "nasal addiction" where the drug works for shorter durations over time (**Tachyphylaxis**). * **Examination:** The nasal mucosa typically appears **beefy red**, granular, and edematous (unlike the pale/bluish mucosa of allergic rhinitis). * **Prevention:** Advise patients never to use topical decongestants for more than **5 consecutive days**.

Practice by Chapter

Functional Endoscopic Sinus Surgery

Practice Questions

Balloon Sinuplasty

Practice Questions

Extended Endoscopic Approaches

Practice Questions

Frontal Sinus Surgery

Practice Questions

Sphenoid Sinus Surgery

Practice Questions

CSF Rhinorrhea Repair

Practice Questions

Revision Sinus Surgery

Practice Questions

Nasal Polyposis Management

Practice Questions

Invasive Fungal Sinusitis

Practice Questions

Orbital Complications of Sinusitis

Practice Questions

Intracranial Complications of Sinusitis

Practice Questions

Olfactory Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Rhinology — MCQs

Rhinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?